| HOME >> BIOLOGY >> TECHNOLOGY |
Monitoring of viral-mediated oncolysis by PET 248
Oncolytic gene therapy 248
Companies developing oncolytic viruses 249
Apoptotic approach to improve cancer gene therapy 249
Tumor suppressor gene therapy 250
P53 gene therapy 250
BRIT1 gene therapy 250
Nitric oxide-based cancer gene therapy 251
Nitric oxide synthase II DNA injection 251
Gene therapy for radiosensitization of cancer 251
Gene therapy of cancer of selected organs 251
Gene therapy for bladder cancer 251
Gene therapy for glioblastoma multiforme. 252
Targeted adenoviral vectors 253
Genetically engineered MSCs for gene delivery to intracranial gliomas 254
Targeting normal brain cells with an AAV vector encoding interferon-b 254
Viral oncolysis of brain tumors 254
Autophagy induced by conditionally replicating adenoviruses 255
Oncolytic virus targeted to brain tumor stem cells 255
Antiangiogenic gene therapy 256
Baculovirus vector for diphtheria toxin gene therapy 256
Intravenous gene delivery with nanoparticles into brain tumors 256
Gene therapy targeting hepatocyte growth factor 257
RNAi gene therapy of brain cancer 257
Ligand-directed delivery of dsRNA molecules targeted to EGFR 257
Gene therapy for breast cancer 258
Gene vaccine for breast cancer 258
Recombinant adenoviral ErbB-2/neu vaccine 259
Gene Therapy for ovarian cancer 259
Gene therapy for malignant melanoma 260
Gene therapy of lung cancer 262
Intravenous nanoparticle formulation for delivery of FUS1 gene 262
Aerosol gene delivery for lung cancer 263
Gene therapy for cancer of prostate 263
Experimental studies 263
Nanoparticle-based gene therapy for prostate cancer 263
Tumor suppressor gene therapy in prostate cancer 264
Vaccines for prostate cancer 264
Clinical trials 2
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |